CAM
Cormorant Asset Management’s VYNE Therapeutics VYNE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
+1,370,938
| New | +$2.26M | 0.17% | 41 |
|
|
2025
Q1 | – | Sell |
-1,394,336
| Closed | -$4.67M | – | 48 |
|
|
2024
Q4 | $4.67M | Hold |
1,394,336
| – | – | 0.26% | 38 |
|
|
2024
Q3 | $2.62M | Hold |
1,394,336
| – | – | 0.14% | 42 |
|
|
2024
Q2 | $2.75M | Hold |
1,394,336
| – | – | 0.16% | 44 |
|
|
2024
Q1 | $4.28M | Hold |
1,394,336
| – | – | 0.19% | 55 |
|
|
2023
Q4 | $3.25M | Buy |
+1,394,336
| New | +$3.25M | 0.16% | 45 |
|
|
2018
Q2 | – | Sell |
-336,714
| Closed | -$12.7M | – | 58 |
|
|
2018
Q1 | $12.7M | Buy |
+336,714
| New | +$12.7M | 0.94% | 23 |
|